Weighing Disease-Modifying Therapy Discontinuation in Older, Stable Patients With MS

John Corboy, MD, professor of neurology at the University of Colorado, discussed recent findings focused on disease-modifying therapy discontinuation in older, stable patients with multiple sclerosis.